• National Pregnancy Registry

    New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

    Despite the increasing use of the newer atypical or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including psychotic disorders, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little [...]

    New Research from the CWMH: Gestational Weight Gain in Women Taking Second Generation Antipsychotics During Pregnancy

    The use of the newer “atypical” or second-generation antipsychotic (SGA) agents continues to increase.  These medications are used to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and anxiety disorders. [...]

    Latest News From the National Pregnancy Registry

    We would like to thank you for your continuing support of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA) at the Center for Women’s Mental Health at Massachusetts General Hospital. We are grateful for all the referrals made to the Registry as our numbers continue to grow every day. Given the Registry’s successful enrollment, we are pleased to announce our plan to release preliminary data at an upcoming conference in June, the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

    Go to Top